>

Health And Medicine

  • Vanderbilt University

    Long-term brain impairment too common after critical illness

    A recent Vanderbilt study shows a significant number of patients are entering I.C.U.’s throughout the world with no evidence of cognitive — brain related issues, but are leaving with symptoms associated with mild Alzheimer’s or Traumatic Brain Injury. Barb Cramer has more. Read More

    Oct 8, 2013

  • ICU monitor and bed

    Study finds cognitive deficits common after critical illness

    Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine. Read More

    Oct 3, 2013

  • Vanderbilt University

    Framingham Heart Study’s landmark impact examined

    While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease. Read More

    Oct 3, 2013

  • Vanderbilt University

    Early cell death in MS

    Death of oligodendrocytes, the cells that make myelin, appears to be an early event in the development of multiple sclerosis. Read More

    Oct 2, 2013

  • Vanderbilt University

    Gene interactions and cavities

    Vanderbilt researchers used existing genome-wide association study datasets to identify gene interactions that contribute to tooth decay. Read More

    Sep 30, 2013

  • Vanderbilt University

    Metabolic profiling of vision loss

    A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis. Read More

    Sep 27, 2013

  • Stomach

    Cell changes en route to stomach cancer

    Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer. Read More

    Sep 26, 2013

  • Vanderbilt University

    Vaccine Research Program lands major NIH renewal

    The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units. Read More

    Sep 26, 2013

  • Vanderbilt University

    Sosman named one of ‘hottest’ researchers in U.S.

    Jeffrey Sosman, M.D., professor of Medicine, Ingram Chair for Cancer Research and director of the Vanderbilt Melanoma Program, was named one of the Hottest Scientific Researchers of the last year by Thomas Reuters Science Watch. Read More

    Sep 26, 2013

  • Vanderbilt University

    Age doesn’t impact concussion symptoms: study

    Recent scientific findings have raised the fear that young athletes may fare worse after sustaining a sports-related concussion than older athletes. Read More

    Sep 26, 2013

  • pregnant belly - striped shirt

    Group prenatal care led to improved birth outcomes

    Women with access to group prenatal care had improved birth outcomes, including longer gestational periods and higher birth weight, in a study conducted by researchers at Vanderbilt’s Peabody Research Institute. Read More

    Sep 19, 2013

  • syringe

    VU testing vaccine against new flu threat

    Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring. Read More

    Sep 19, 2013

  • Vanderbilt University

    VU study brings genome’s ‘dark matter’ into light

    Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer. Read More

    Sep 19, 2013

  • Vanderbilt University

    Fishing for new anti-cancer drugs

    Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug. Read More

    Sep 18, 2013

  • Vanderbilt University

    Mapping brain membrane proteins

    New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues. Read More

    Sep 16, 2013

  • Vanderbilt University

    Cancer nanomedicines on target

    Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time. Read More

    Sep 13, 2013

  • Deciphering DNA code

    VU study identifies DNA changes in drug-resistant cancer cells

    Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read More

    Sep 12, 2013

  • Vanderbilt University

    VU tracking drug’s ability to prevent type 1 diabetes

    Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D. Read More

    Sep 12, 2013

  • research default banner

    Two named to National Academies’ advisory board

    Vanderbilt University’s Roger D. Cone, Ph.D., and Elizabeth Heitman, Ph.D., have been appointed to the National Academies’ Board on Life Sciences, which advises the government and scientific community on a wide range of topics, from stem cell research to bioterrorism. Read More

    Sep 12, 2013

  • Vanderbilt University

    Sleep education helps families of children with autism

    Parent sleep education is beneficial in improving sleep and aspects of daytime behavior and family functioning in children with autism spectrum disorders (ASD), according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders. Read More

    Sep 12, 2013